What is the current stock price of CVRx, Inc. (CVRX)?

As of the latest market data, CVRx, Inc. (CVRX) is trading at $5.78. The stock has seen a loss of -4.93% today.

Does CVRx, Inc. (CVRX) pay a dividend?

Based on current data, CVRx, Inc. does not have a confirmed active dividend policy.

What is the market cap of CVRx, Inc.?

The current market capitalization of CVRx, Inc. (CVRX) is approximately unavailable.

CVRX

CVRx, Inc.·Healthcare

5.78

4.934%(−0.30)

Close Price

6.61

14.360%(+0.83)

Pre-Market

Last Updated: — ET

52W L: $4.3752W H: $11.30

CVRX NEWS

globenewswire.com

13h ago

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on Wednesday, June 10, 2026. The Company's presentation will begin at 8:00 a.m. (ET).

globenewswire.com

13h ago

CVRx to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

MINNEAPOLIS, May 27, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami on Wednesday, June 10, 2026.

globenewswire.com

May 20

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Tuesday, June 2, 2026. The Company's presentation will begin at 10:40 a.m. (CT).

globenewswire.com

May 20

CVRx to Present at the William Blair 46th Annual Growth Stock Conference

MINNEAPOLIS, May 20, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that the management team will present at the William Blair 46th Annual Growth Stock Conference in Chicago on Tuesday, June 2, 2026.

zacks.com

May 18

CVRx Stock Up on Humana's Medicare Coverage for Barostim Therapy

CVRX stock gains after Humana adds Medicare Advantage coverage for Barostim therapy, boosting reimbursement momentum and patient access.

globenewswire.com

May 14

CVRx Announces Humana Medicare Advantage Coverage Policy for Barostim Therapy

MINNEAPOLIS, May 14, 2026 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases, announced today that Humana has issued a Medicare Advantage coverage policy for Barostim therapy, effective May 1, 2026. Humana, a national health insurance company with the second largest Medicare Advantage program in the U.S., provides coverage to approximately 5.2 million Medicare Advantage members across 46 states.

Company Profile

CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. It offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure (HF) with reduced ejection fraction or systolic HF. The company sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, rest of Europe, and internationally. CVRx, Inc. was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.

Sector

Healthcare

Industry

Medical - Devices

Employees

206

IPO Date

2021-06-30

Beta

0.87

Websitewww.cvrx.com↗